Europe Neuropathic Pain Market to 2032
Overview
The Europe Neuropathic Pain Market is expected to reach a 2,807.30 by 2032 and is projected to grow at a CAGR of 8.95% from 2025 to 2032.
Revenue, 2024 ()
1,389.25
Forecast, 2032 ()
2,807.30
CAGR, 2024 - 2032
8.95%
Report Coverage
Europe
Europe Neuropathic Pain Market 2018-2032
Europe Neuropathic Pain Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,389.25
- Projected Market Size (2032): 2,807.30
- CAGR (2025-2032): 8.95%
Key Findings of Europe Neuropathic Pain Market
- The Europe Neuropathic Pain Market was valued at 2,807.30 in 2024.
- The Europe Neuropathic Pain Market is likely to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Devices in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 1,053.09
- The fastest growing segment Peripheral Neuropathy in Pain Type Segment grew Fastest with a CAGR of 10.56% during the forecast period from 2024 to 2032.
Europe Neuropathic Pain Market Scope
Europe Neuropathic Pain Market Segmentation & Scope
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Europe Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 1,389.25 |
| Market Value in 2032 | 2,807.30 |
| CAGR (2025-2032) | 8.95% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Product Type,Procedure,Technology,Modality,Indication,End User,Distribution Channel,Mode of Purchase,Pain Type |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 1,389.25 in 2024
- Key Country: Germany, leading in terms of revenue with value of 293.47 USD Million in 2024.
Segments and Scope
-
Europe Neuropathic Pain Market to 2032, By Type
- Spinal Cord Stimulation (SCS) Devices is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 847.06 in the year 2024.
- Spinal Cord Stimulation (SCS) Devices is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.20 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Product Type
- Rechargeable is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 905.78 in the year 2024.
- Non-Rechargeable is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 8.71 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Procedure
- Non-Invasive is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 990.41 in the year 2024.
- Non-Invasive is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.06 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Technology
- Transcutaneous Electrical Nerve Stimulation is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 816.18 in the year 2024.
- Transcutaneous Electrical Nerve Stimulation is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.21 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Modality
- Portable is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 902.65 in the year 2024.
- Stationary is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 8.84 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Indication
- Spinal Stenosis is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 576.86 in the year 2024.
- Diabetic Neuropathy is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 8.85 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By End User
- Clinics is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 447.43 in the year 2024.
- Hospitals is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.44 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 914.85 in the year 2024.
- Direct Tenders is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.15 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Mode of Purchase
- Prescription-Based Devices is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 1,053.09 in the year 2024.
- Prescription-Based Devices is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 9.06 % in forecast period 2025-2032.
-
Europe Neuropathic Pain Market to 2032, By Pain Type
- Peripheral Neuropathy is the largest segment in Europe Neuropathic Pain Market to 2032 with a revenue of 312.05 in the year 2024.
- Peripheral Neuropathy is the Fastest growing segment in Europe Neuropathic Pain Market to 2032 with a Growth rate of 10.56 % in forecast period 2025-2032.
Europe Neuropathic Pain Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Medtronic | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Omron Healthcare | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| NEVRO CORP. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Integer Holdings Corporation | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Boston Scientific Corporation or its affiliates | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Abbott | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Europe Neuropathic Pain Market Geographical Sales Distribution, 2018-2032
Europe Neuropathic Pain Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Neuropathic Pain Market is segmented based on Segmentation Type,Product Type,Procedure,Technology,Modality,Indication,End User,Distribution Channel,Mode of Purchase,Pain Type.
Europe Neuropathic Pain Market was valued at USD 1,389.25(Revenue in ) in 2020.
Europe Neuropathic Pain Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The Prescription-Based Devices segment is expected to dominate the Europe Neuropathic Pain Market, holding a largest market share of 1,053.09 in 2024
Europe Neuropathic Pain Market Scope
Europe Neuropathic Pain Market Segmentation & Scope
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Modality
- Stationary
- Portable
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Frequently Asked Questions
The Europe Neuropathic Pain Market is segmented based on Segmentation Type,Product Type,Procedure,Technology,Modality,Indication,End User,Distribution Channel,Mode of Purchase,Pain Type.
Europe Neuropathic Pain Market was valued at USD 1,389.25(Revenue in ) in 2020.
Europe Neuropathic Pain Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Neuropathic Pain Market for final year is USD 2,807.30 ().
Europe Neuropathic Pain Market Company Profiling
Frequently Asked Questions
The Europe Neuropathic Pain Market is segmented based on Segmentation Type,Product Type,Procedure,Technology,Modality,Indication,End User,Distribution Channel,Mode of Purchase,Pain Type.
Europe Neuropathic Pain Market was valued at USD 1,389.25(Revenue in ) in 2020.
Europe Neuropathic Pain Market is projected to grow at a CAGR of 8.95% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Neuropathic Pain Market for final year is USD 2,807.30 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.